Technology foresight for medical device development through hybrid simulation: The ProHTA Project

Results of the simulation show that MSUs save up to 49 min of time between ambulance call and therapy decision. Whereas without MSUs, only 0.2% of patients fall in the group with the most favourable time interval between 0 and 90 min, up to 16.6% of patients treated in MSUs fall into this group of early onset times to thrombolysis. As a flexible and primarily quantitative decision-making tool for foresight, ProHTA adds value to existing methodologies for pre-assessing health technology at a very early stage of technology research and development. With its emphasis on strategic planning, ProHTA helps to improve the efficiency of health care delivery in different settings using hybrid simulation techniques.